WHA68 KEI side event: Andrew Goldman speaking on compulsory licensing of HCV drug patents

On Thursday, May 21, 2015, KEI and KEI Europe hosted a side event at the 68th World Health Assembly on compulsory licensing of patents on drugs, vaccines, and diagnostic tests. The event was graciously hosted by UNAIDS in the Kofi Annan room.

During the panel, Andrew Goldman, Counsel for Policy and Legal Affairs at KEI, spoke about KEI’s recent efforts to increase access to hepatitis C virus (HCV) treatments in Romania through the use of compulsory licensing. He also spoke about our compulsory licensing efforts in other countries, and on methods to set royalties for licenses on HCV patents. See below for a full video of Mr. Goldman’s remarks:

For links to the voluntary license requests that propose an innovative royalty structure that accounts for the complexities of income disparities, HCV types, and incidences, please visit KEI Europe’s page on licensing here: http://keieurope.org/licences.html

Claire Cassedy